Evidence map›Paper›PMID 38628622›Full record

ArticleThe journal of venomous animals and toxins including tropical diseases2024

Heterologous fibrin biopolymer as an emerging approach to peripheral nerve repair: a scoping review.

Kevin Silva Muller, Felipe Cantore Tibúrcio, Rui Seabra Ferreira, Benedito Barraviera, Selma Maria Michelin Matheus

Open access · goldAbstract readScoping Review
In one paragraph

Article in The journal of venomous animals and toxins including tropical diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Kevin Silva MullerDepartment of Structural and Functional Biology, São Paulo State University (UNESP), Botucatu Institute of Biosciences, Botucatu, SP, Brazil.ORCID 0000-0001-9774-1435
Felipe Cantore TibúrcioDepartment of Structural and Functional Biology, São Paulo State University (UNESP), Botucatu Institute of Biosciences, Botucatu, SP, Brazil.ORCID 0000-0003-2660-6089
Rui Seabra FerreiraBotucatu Medical School, São Paulo State University (UNESP), Botucatu, SP, Brazil.ORCID 0000-0001-6952-0512
Benedito BarravieraBotucatu Medical School, São Paulo State University (UNESP), Botucatu, SP, Brazil.
Selma Maria Michelin MatheusDepartment of Structural and Functional Biology, São Paulo State University (UNESP), Botucatu Institute of Biosciences, Botucatu, SP, Brazil.ORCID 0000-0001-7870-5404
Universidade Estadual Paulista (Unesp) · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nerve injuries present a substantial challenge within the medical domain due to their prevalent occurrence and significant impact. In nerve injuries, a range of physiopathological and metabolic responses come into play to stabilize and repair the resulting damage. A critical concern arises from the disruption of connections at neuromuscular junctions, leading to profound degeneration and substantial loss of muscle function, thereby hampering motor tasks. While end-to-end neurorrhaphy serves as the established technique for treating peripheral nerve injuries, achieving comprehensive morphofunctional recovery remains a formidable challenge. In pursuit of enhancing the repair process, alternative and supportive methods are being explored. A promising candidate is the utilization of heterologous fibrin biopolymer, a sealant devoid of human blood components. Notably, this biopolymer has showcased its prowess in establishing a stable and protective microenvironment at the site of use in multiple scenarios of regenerative medicine. Hence, this scoping review is directed towards assessing the effects of associating heterologous fibrin biopolymer with neurorrhaphy to treat nerve injuries, drawing upon findings from prior studies disseminated through PubMed/MEDLINE, Scopus, and Web of Science databases. Further discourse delves into the intricacies of the biology of neuromuscular junctions, nerve injury pathophysiology, and the broader utilization of fibrin sealants in conjunction with sutures for nerve reconstruction procedures. The association of the heterologous fibrin biopolymer with neurorrhaphy emerges as a potential avenue for surmounting the limitations associated with traditional sealants while also mitigating degeneration in nerves, muscles, and NMJs post-injury, thereby fostering a more conducive environment for subsequent regeneration. Indeed, queries arise regarding the long-term regenerative potential of this approach and its applicability in reconstructive surgeries for human nerve injuries.

Indexed as

Fibrin sealantNervous systemNeurorrhaphyRegenerative medicine

Identifiers

PMID38628622
PMCPMC11019597
OpenAlexW4394828579

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.